Pairnomix CEO presents company’s personalized approach to genetic research at 2016 Epilepsy Foundation pipeline conference

Pairnomix CEO Matthew Fox was among the leading decision-makers included in this year’s Epilepsy Foundation Pipeline Conference. Fox presented an overview of how the personalized genetic research company is helping epilepsy patients better understand their disorder.